QuantX Dynamic Beta US Equity ETF
XUSA
XUSA was delisted on the 16th of May, 2019.
3 hedge funds and large institutions have $41.7M invested in QuantX Dynamic Beta US Equity ETF in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less capital invested
Capital invested by funds: $49.5M → $41.7M (-$7.79M)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$159K |
| 2 |
ACP
Aveo Capital Partners
Englewood,
Colorado
|
+$47.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$11.9M |
| 2 |
Jane Street
New York
|
-$313K |
XUSA Hedge Fund Activity: Q4 2017 in Review
3 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in QuantX Dynamic Beta US Equity ETF (XUSA) for Q4 2017, worth a combined $41.7M — down 16% from $49.5M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of XUSA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Virtu Financial, adding an estimated $159K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $11.9M sold.
- 3 institutional investors held QuantX Dynamic Beta US Equity ETF (XUSA) as of Q4 2017, down from 5 in Q3 2017.
- Funds reported $41.7M of QuantX Dynamic Beta US Equity ETF stock for Q4 2017, down 16% quarter-over-quarter.
- 0 funds opened new QuantX Dynamic Beta US Equity ETF positions in Q4 2017 and 2 closed out, a net change of -2 holders.
- The largest QuantX Dynamic Beta US Equity ETF buyer in Q4 2017 was Virtu Financial, an estimated $159K added.
- The largest QuantX Dynamic Beta US Equity ETF seller in Q4 2017 was JP Morgan Chase, an estimated $11.9M sold.
Based on aggregated 13F filings for Q4 2017.